Sotera Health (NASDAQ:SHC) Releases Earnings Results, Beats Expectations By $0.02 EPS

Sotera Health (NASDAQ:SHC - Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.12 by $0.02, Briefing.com reports. The firm had revenue of $254.52 million during the quarter, compared to analyst estimates of $245.56 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. Sotera Health's revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.13 EPS. Sotera Health updated its FY 2025 guidance to 0.700-0.760 EPS.

Sotera Health Price Performance

SHC traded up $0.28 during trading on Friday, reaching $12.38. 1,075,697 shares of the company traded hands, compared to its average volume of 1,204,736. The company has a market cap of $3.51 billion, a P/E ratio of 49.52 and a beta of 1.88. Sotera Health has a 12-month low of $9.53 and a 12-month high of $17.08. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The firm has a fifty day simple moving average of $11.38 and a 200 day simple moving average of $13.04.

Wall Street Analysts Forecast Growth

SHC has been the subject of a number of analyst reports. Barclays reduced their price target on Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Piper Sandler reduced their target price on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, Sotera Health has a consensus rating of "Moderate Buy" and an average target price of $15.20.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.